期刊文献+

辣椒素对人结肠癌SW480细胞株增殖作用的影响 被引量:1

EFFECT OF CAPSAICIN ON PROLIFERATION OF CELL LINE SW480 IN HUMAN COLON CARCINOMA
在线阅读 下载PDF
导出
摘要 目的了解辣椒素对人结肠癌SW480细胞株增殖作用的影响,并探讨其可能的作用机制。方法采用MTT检测法,观察终浓度100-400μmol/L的辣椒素作用24、48 h对人结肠癌SW480细胞株生长作用的影响;采用流式细胞仪检测400μmol/L辣椒素作用人结肠癌SW480细胞株后其细胞周期变化和凋亡率。结果辣椒素能抑制结肠癌SW480细胞株增殖,呈浓度、时间依赖性。在400μmol/L辣椒素作用下,结肠癌SW480细胞株停滞于G0/G1期。辣椒素作用24、48 h,SW480细胞凋亡率升高(F=8.73、8.10,q=4.86-7.30,P〈0.01)。结论辣椒素抑制SW480细胞增殖,并诱导其凋亡,其机制可能是阻滞细胞周期于G0/G1期。 Objective To study the effect of capsaicin on proliferation of human colon-carcinoma cell line(SW480) and its possible mechanism. Methods MTT colorimetry was used to check the effect of 24-,48-hour action of capsaicin on proliferation of SW480 with dosage ranged from 100-400 μmol/L.The cell cycle and apoptosis under the capsaicin with a dosage of 400 μmol/L was detected by flow cytometry. Results Capsaicin inhibited the proliferation of SW480 cell line in a dosage-and time-dependent manner.At the dosage of 400 μmol/L,SW480 stagnated at phase G0/G1.The apoptosis rate increased after capsaicin action for 24 and 48 hours compared with that of the control group(F=8.73,8.10;q=4.86-7.30;P〈0.01). Conclusion Capsaicin in vitro inhibits proliferation of SW480 cells and induces their apoptosis,blockage of cell cycle at phase G0/G1 might be its mechanism.
出处 《齐鲁医学杂志》 2011年第1期11-12,16,共3页 Medical Journal of Qilu
关键词 辣椒素 结肠肿瘤 细胞增殖 细胞凋亡 capsaicin colonic neoplasms cell proliferation apoptosis
作者简介 梁晨(1973-),男,硕士,主治医师。
  • 相关文献

参考文献2

二级参考文献40

  • 1ELSAYAD Y A,SAUSVILLE E A.Selected novel anticancer treatments targeting cell signalling protein[J].Oncologist,2001,6(6):517-537.
  • 2MEYER U A.Pharmacogenetics and adverse drug reactions[J].Lancet,2000,356(9242):1667-1671.
  • 3PULLARKAT S T,STOEHLMACHER J,GHADERI V,et al.Thymidylate synthase gene polymorphism determines response and toxicity of 5-Fu chemotherapy[J].Pharmaco-genomics J,2001,1(1):65-70.
  • 4STOEHLMACHER J,PARK D J,ZHANG W,et al.Association between glutathione S-transferase P1,T1,and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer[J].J Natl Cancer Inst,2002,94(12):936-942.
  • 5CHEN C.Risk of prostate cancer in relation to polymorphisms of metabolic genes[J].Epidemiol Rev,2001,23(1):30.
  • 6LONDON S J,YUAN J M,CHUNG F L,et al.Isothiocyanates,glutathione S-transferase M1 and G1 polymorphisms,and lung cancer risk:a prospective study of men in Shanghai[J].China P Lancet,2000,25(8):724.
  • 7CURRAN J E,WEINSTEIN S R,GRIFFITHS L R.Polymorphisms of glutathione S-transferase genes(GSTM1,GSTP1 and GSTT1) and breast cancer susceptibility[J].Cancer Letters,2000,28(11):113.
  • 8HOWELLS R E,HOLLAN D T,DHAT K K,et al.Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer:association with p53 expression and surviva1[J].Int J Gynecol Cancer,2001,29(12):107.
  • 9BEEGHLY A,KATSAROSD,CHEN H,et al.Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival[J].Gynecol Oncol,2006,100(2):330-337.
  • 10GOEKKURT E,HOEHN S,WOLSCHKE C,et al.Polymorphisms of glutathione S2transferases (GST) and thymidylate synthase (TS)2 novel predictors for response and survival in gastric cancer patients[J].Br J Cancer,2006,94(2):281-286.

共引文献14

同被引文献15

  • 1JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics, 2008[J]. CA Cancer J Clin, 2008,58(2) :71-96.
  • 2ZHAO B, LEI Q Y, GUAN K L. The Hippo-YAP pathway: new connections between regulation o5 organ size and cancer [J]. Curr Opin Cell Biol, 2008,20(6) : 638-646.
  • 3PAN D. Adjuvant capecitabine and oxaliplatin for gastric cancer af- ter D2 gastrectomy(CLASSIC) : a phase 3 open-label, randomized controlled trial[J]. Lancet, 2012,379(9813) : 315-321.
  • 4ZHENG T, WANG J, JIANG H, etal. Hippo signaling in oval cells and hepatocarclnogenesis[J]. Cancer Lett, 2011,302(2) :91-99.
  • 5BADOUEL C GARG A MCiNEILL H. Herding hippos; re- gulating growth in flies and man[J]. Curr Opin Cell Biol, 2009,21(6) :837-843.
  • 6ZENG Q, HONG W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer deve- lopment in mammals[J]. Cancer Cell, 2008,13(3):188-192.
  • 7YU F X, ZHAO B, PANUPINTHU N, et al. Regulation of the Hippo-YAP pathway by g-protein-coupled receptor signa- ling[J]. Cell, 2012,150(4) ..780-791.
  • 8MORINAKA A, FUNATO Y, UESUGI K, et al. Oligomeric peroxiredoxin-I is an essential intermediate for p53 to acti- vate MST1 kinase and apoptosis[J]. Oncogene, 2011, 30 (40) :4208-4218.
  • 9WANG L, SHI S, GUO Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells[J]. PLoS One, 2013,8(6) : e65539.
  • 10AVRUCH J, ZHOU D, FITAMANT J, et al. Mstl/2 signal- ling to Yap gatekeeper for liver size and turnout development [J]. Br J Cancer, 2011,104(1) :24-32.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部